Hanjing Xie is born 1970 and Chief Medical Officer at Kancera AB. Dr. Xie is associate professor and senior consultant in oncology, holds a Ph.D. in clinical pharmacology and board certifications in clinical oncology, internal medicine and hematology. She has 30 years of combined experience from research and clinical development and as physician. Dr. Xie has experience from both the pharmaceutical industry, at companies such as Idogen, Oncopeptides and Bayer, and from university hospitals and institutes, such as the Karolinska University Hospital, the Karolinska Institute and St. Göran’s hospital.
Back